About
Basic Data Updated:
2 days agoStrides Pharma Science Limited, previously known as Strides Arcolab Limited, is a medium sized pharmaceutical company. It is involved in the development, manufacturing, and export of a diverse range of pharmaceutical products. The company's product portfolio encompasses various dosage forms such as tablets, capsules, and semi-solids. Currently, the company's operations are primarily divided into three categories - regulated markets formulations, emerging markets, and the institutional segment. The regulated markets formulations mainly include the US, Europe, and Australia, while the emerging markets primarily consist of Africa. The institutional segment focuses on tender-driven business, primarily in developing markets. Our goal is to ensure that our description effectively communicates t... Read More
Industry
Company Details
- Location
Thane, Maharashtra, India
- Website1222442
- Telephone1222442
- Email Address1222442
- Social Media1222442
Products or Services related to Strides Pharma Science Limited
Malaria Medicine
Financials of Strides Pharma Science Limited
Strides Pharma Science Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.8% decrease. The company also saw a substantial fall in profitability, with a 97.4% decrease in profit. The company's net worth moved up by a moderate rise of 1.42%.
Enhance accessibility to Strides Pharma Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Corporate Structure
Unlock access to Strides Pharma Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Strides Pharma Science Limited
Unlock and access historical data on people associated with Strides Pharma Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
AP
Arun Pillai
Managing DirectorAppointment Date: 24-May-2004
Status: Current
MR
Manjula Ramamurthy Company SecretaryStatus: Current
BK
Badree Komandur CFOStatus: Current
Board Members(6)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 20 Dec 2023 | ₹139.62 Cr | Open |
Others Creation Date: 19 Sep 2023 | ₹150.00 Cr | Open |
Others Creation Date: 31 Aug 2023 | ₹250.00 Cr | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Strides Pharma Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Strides Pharma Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
16 years 4 months 
Recent activity within the organization
Director Appointment
Ameet Pratapsinh Hariani was appointed as a Additional Director was appointed as a Additional Director on 04 Mar 2024 & has been associated with this company since 2 months 4 days .
04 Mar 2024Charges
A charge registered on 28 Dec 2018 via Charge ID 100232218 with Others was fully satisfied on 19 Jan 2024.
19 Jan 2024Charges
A charge with Others of Rs. 1,447.00 cr registered on 19 Jul 2016 with Charge ID 100062848 was modified on 17 Jan 2024.
17 Jan 2024Charges
A charge registered on 24 Jan 2023 via Charge ID 100676585 with Others was fully satisfied on 12 Jan 2024.
12 Jan 2024Charges
A charge registered on 21 Apr 2022 via Charge ID 100574066 with Others was fully satisfied on 02 Jan 2024.
02 Jan 2024
Recent News, Updates & Announcement
Strides Pharma gains after arm receives USFDA nod for Pregabalin capsule.Moneycontrol 29 Jan 2024
- CMS00867 Joins Hands with Pharmaron to Promote the Singapore Manufacturing Plant Acquisition and CDMO Business in SEA.
SHENZHEN CHINA Jan 02 2024 GLOBE NEWSWIRE On 29 December 2023 PharmaGend Global Medical Services Pte Ltd PharmaGend jointly invested.
China Medical System Holdings Ltd 02 Jan 2024
- Teva Names R Ananth CEO for API Business.
Contract Pharma 08 Nov 2023
- Strides Pharma gets USFDA nod to market HIV drug.
The companys product is bioequivalent and therapeutically equivalent to Atripla Tablets of Gilead Sciences LLC it added As per per IQVIA Efavirenz Emtricitabine and Tenofovir Disoproxil Fumurate tablet EET has a market opportunity of USD 75 million in the US.
Economic Times 04 Oct 2023
- Strides Pharma Signs 57197 SF Industrial Lease in Pearl River New York.
REBusinessOnline 08 Jul 2023
Frequently asked questions
What is the Incorporation or founding date of Strides Pharma Science Limited?
